Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes
Open Access
- 13 March 2014
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 123 (11) , 1699-1708
Abstract
Key Points: Unsupervised clustering of DLBCLs based on DNA methylation changes identifies 6 novel epigenetic clusters. Greater magnitude of methylation changes correlates with worse clinical outcome.Keywords
This publication has 55 references indexed in Scilit:
- Using biologic predictive factors to direct therapy of diffuse large B-cell lymphomaTherapeutic Advances in Hematology, 2012
- Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemiaNature Genetics, 2012
- Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypesGenes, Chromosomes and Cancer, 2012
- The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular LymphomaCell, 2011
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphomaNature, 2011
- Identification and functional relevance of de novo DNA methylation in cancerous B‐cell populationsJournal of Cellular Biochemistry, 2010
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid LeukemiaCancer Cell, 2010
- DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression statusLeukemia, 2008
- Genomic DNA methylation: the mark and its mediatorsTrends in Biochemical Sciences, 2006
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000